OG0-092: TOGAF 9 Part 2 Exam

By The Open Group · Question Mode

QuestionQ14

VerifiedThe TOGAF Standard, Version 9.2

You have been asked to recommend how this situation should be managed during the implementation-planning phases.

Based on TOGAF 9, which of the following is the best answer?

Explanation

TOGAF 9 Phase E reviews the Business Transformation Readiness Assessment and manages risks associated with readiness factors. Resistance to sharing clinical-trial information because of identifiable-subject privacy concerns is a readiness risk that should be identified, classified, and mitigated before defining a high-level solutions strategy and the Transition Architectures needed to make the change culturally and technically feasible.

Learn more

Community Discussion

No comments yet. Be the first to start the discussion!